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Objectives: The objectives were to study a possible outbreak of carbapenem-resistant Acinetobacter baumannii
by comparing three different typing methods (PFGE, MLST and whole-genome SNPs) and to compare the
resistance gene profiles of the isolates.
Methods: From December 2012 to October 2013, eight carbapenem-resistant A. baumannii were detected at
Odense University Hospital, Odense, Denmark. These isolates were typed by PFGE, with ApaI and SmaI, respect-
ively, and subjected to WGS. The WGS data were used for in silico extraction of MLST types using two different
schemes, resistance genes and SNPs, to which 31 publicly available A. baumannii genomes were added.
Results: Using ApaI, the eight isolates had four different PFGE profiles, which were further differentiated using
SmaI, separating one of the profiles into two distinct PFGE types. Five ST2 (Pasteur MLST) OXA-23-producing iso-
lates, two ST1 OXA-72-producing isolates and one ST158 OXA-23-producing isolate were detected. The five ST2
isolates were subdivided into ST195, ST208 and ST218 using the Oxford MLST scheme. The phylogenetic analysis
based on the core genome showed that six of the eight Danish A. baumannii isolateswere located in three distinct
clusters. The two remaining isolates did not cluster with other Danish or international isolates included in the
study. Isolates that clustered using PFGE, Oxford MLST and phylogenetic analysis also shared similar resistance
gene profiles.
Conclusions: The SNP profile, Oxford MLST, PFGE and resistance gene profiles clearly indicated spread of three
different A. baumannii strains.
Keywords: antimicrobial resistance, antimicrobial resistance epidemiology, carbapenems
Introduction
Carbapenem resistance in Acinetobacter baumannii is most often
encoded by oxacillinases (OXAs) and less frequently by metallo-
b-lactamases.1 Four main OXA groups, which can be further sub-
grouped, have been associated with carbapenem resistance in
A. baumannii: the chromosomally located intrinsic OXA-51-like
group and the three acquired OXA groups—OXA-23-like,
OXA-40-like and OXA-58-like.2,3 Furthermore, two novel OXA
enzymes, OXA-143 and OXA-235, were detected in A. baumannii
isolates in 2009 and 2013, respectively.4,5
Spread of A. baumannii in hospitals has been investigated by
several typing methods. The most commonly used method for
investigation of clonality is PFGE using ApaI as the restriction
enzyme.2 For investigation of population structure and global bac-
terial epidemiology, MLST has been the golden standard.2 There
are two MLST schemes for A. baumannii: the Oxford MLST scheme
and the Pasteur MLST scheme (http://pubmlst.org/abaumannii).
Furthermore, WGS can be used for comparison of A. baumannii
isolates.
In recent years, Danish departments of clinicalmicrobiology have,
on a voluntary basis, submitted carbapenem-resistant A. baumannii
isolates for verification and genotyping at the Antimicrobial
Resistance Reference Laboratory at Statens Serum Institut.
To our knowledge, spread of OXA-23-producing A. baumannii
has previously only been detected at one hospital in the Capital
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Region in Denmark, whereas single cases of OXA-23-like- or
OXA-40-like-producing A. baumannii, most often related to prior
travel, have been reported in other parts of Denmark too.6,7
The aim of this study was: (i) to study possible outbreak(s)
of carbapenem-resistant A. baumannii detected at Odense
University Hospital using three different typing methods [PFGE,
MLST (two different schemes) and SNP analysis]; (ii) to compare
these typing methods; and (iii) to compare the resistance gene
profiles detected from the whole-genome sequences.
Methods
Isolates
In October 2013, carbapenem-resistant A. baumannii were detected in
four patients hospitalized at Odense University Hospital, a tertiary referral
hospital with approximately 1100 beds in the Region of Southern Denmark
(1.2 million inhabitants).
To investigate a possible outbreak, the isolates were characterized
using different typing methods. Their profiles were compared with four
other carbapenem-resistant A. baumannii isolates previously detected at
the hospital (December 2012 to September 2013) (Table 1). The eight iso-
lates were the only carbapenem-resistant A. baumannii isolates detected
during December 2012 to October 2013 at the Department of Clinical
Microbiology at Odense University Hospital. Isolates were identified to spe-
cies level by MALDI-TOF MS.
Susceptibility testing
The eight isolates were tested using Sensititre Trek panels (Thermo
Scientific, Waltham, MA, USA; ampicillin/sulbactam, ticarcillin/clavulanic
acid, piperacillin/tazobactam, ceftazidime, cefoperazone, ceftriaxone,
cefotaxime, cefepime, aztreonam, imipenem, meropenem, lomefloxacin,
ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, gentamicin,
tobramycin, amikacin, tetracycline and colistin) as per the manufacturer’s
instructions. The microbroth dilution method was performed in accord-
ance with the CLSI.8
PCR
The blaOXA genogroups in the eight carbapenem-resistant A. baumannii
isolates were identified by multiplex PCR as previously described.9,10
PFGE
Bacterial DNA for PFGE was prepared using the Salmonella standard proto-
col of CDC PulseNet (http://www.cdc.gov/pulsenet/). Agarose plugs con-
taining DNA were digested with 25 U of the restriction enzyme ApaI or
with 30 U of the restriction enzyme SmaI for 4 h. Electrophoresis (1%
gel) was performed at 6 V/cm and with the following run parameters for
the two different enzymes: ApaI, 5–20 s for 18.5 h; and SmaI, 5–20 s for
18.5 h followed by 5–10 s for 4 h. Addition of thiourea (100 mL of 1 M) in
the running buffer was not able to stop the degradation of the DNA from
two of the strains when digested with SmaI (isolate AMA 517 and isolate
AMA 525). The CDC standard H9812 isolatewas digestedwith 50 U of XbaI
and used as themolecular sizemarker. All visible bandsmore than 55 kb in
size were included in the interpretation of PFGE patterns. An isolate was
considered to be closely related to the outbreak strain if its PFGE pattern
differed from the outbreak pattern by changes consistent with a single
genetic event, i.e. a point mutation or any major insertions or deletions.
Such changes typically result in two or three band differences. Patterns
that were closely or possibly related to the outbreak pattern were consid-
ered subtypes of A and were designated type A1, type A2 etc.11
WGS and assembly
Genomic DNA was extracted (DNeasy Blood and Tissue Kit, Qiagen,
Copenhagen, Denmark) and fragment libraries constructed using the
Nextera Kit (Illumina, Little Chesterford, UK) followed by 251 bp paired-end
sequencing (MiSeq, Illumina) according to the manufacturer’s instructions.
In addition to the eight genomes of the Danish A. baumannii isolates
(NCBI BioProject ID PRJNA266271), the chromosomes of the 31 publicly
available complete and scaffold A. baumannii genomes, representing 31
different genome groups according to GenBank, were included in this
study. The sequence data were aligned against the chromosome of the
A. baumannii BJAB0715 reference genome (GenBank accession ID
CP003847) using the Burrows–Wheeler Aligner (BWA). Identification of
SNP variants was performed using the GATK Unified Genotyper with filter-
ing using NASP (http://tgennorth.github.io/NASP/) to remove positionswith
less than 10× coverage and ,90% unambiguous variant calls, or within
duplicated regions of the reference using NUCmer. Phylogenetic analyses
of the identified SNPs was performed using MEGA 6.0.6.12 The paired-end
Illumina data were assembled using CLCBio’s Genomic Workbench
7.5 (Qiagen, Aarhus, Denmark).
MLST
MLST was performed from the whole-genome sequences of the eight iso-
lates using the MLST web server (www.genomicepidemiology.org).13 Two
different MLST schemes were used: the Oxford MLST scheme and the
Pasteur MLST scheme (http://pubmlst.org/abaumannii).
Identification of resistance genes
The ResFinder web server (www.genomicepdemiology.org) was used
to identify acquired antimicrobial resistance genes in the assembled
WGS data, using a threshold of 100% identity for the genes encoding
b-lactamases and 98.00% identity for all other genes. ResFinder detects
the presence of resistance genes, but not functional integrity and expres-
sion or resistance due to acquired variation in housekeeping genes.14
Results and discussion
Screening for blaOXA geneswithmultiplex PCR detected six isolates
with blaOXA-23-like genes and two isolates with blaOXA-40-like genes
(data not shown). ResFinder analysis of the WGS data identified
blaOXA-23 in the six isolates with blaOXA-23-like genes and blaOXA-72
genes in the two blaOXA-40-like group isolates. Furthermore,
blaOXA-65 (n¼1), blaOXA-66 (n¼5) and blaOXA-92 (n¼2), all belong-
ing to the intrinsic blaOXA-51 group, were identified (Table 1). To our
knowledge, blaOXA-92 is rare and has only previously been reported
from a clinical isolate from a patient in Greece.15
The eight isolates had four different PFGE profiles using ApaI as
restriction enzyme; four of the isolates had related types (B1, B2)
(Table 1 and Figure S1, available as Supplementary data at JAC
Online). PFGE using SmaI as restriction enzyme revealed that
these four isolates comprised two unrelated types (Figure S2).
Using the Pasteur MLST scheme, five of the eight isolates
belonged to ST2 (CC2; where CC stands for clonal complex), two iso-
lates to ST1 (CC1) and one isolate to ST158 (Table 1). The five isolates
belonging to ST2 (using the Pasteur scheme) were further divided
into ST195, ST208 and ST218 using the Oxford MLST scheme.
Furthermore, ST499 and the new ST812 (double-locus variant of
ST321) were identified for three isolates using the Oxford MLST
scheme (Table 1). The Oxford MLST scheme had a higher discrimin-
atory power than the Pasteur MLST scheme.
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Table 1. Description of eight A. baumannii isolates from Odense University Hospital
Isolate
no. Origin
Sample
date
PFGE
ApaI
PFGE
SmaI
Pasteur
MLST
Oxford
MLST SNP profile Background
Patient’s link to
other countries
Resistance
profilea b-Lactamase
Genes encoding
non-b-lactam resistance
AMA
341
respiratory
secretions
16-12-2012 D E 158 499 travel to Egypt 1 blaOXA-23,
blaOXA-65,
blaGES-11
aph(3′)-VI-a, aac(6′)-Ib-cr,
aadB, mph(E), mrs(E),
sul1, dfrA7
AMA
474
drain tip 18-08-2013 C F 2 218 hospitalized in
Slovakia
1 blaOXA-23,
blaOXA-66,
blaADC-25
aadA1, aac(6′)Ib-cr,
aph(3′)-VI-a, aph(3′)Ic,
armA, strB, strA, mph(E),
mrs(E), catB8, sul1, tet(B)
AMA
441
culture from
lower leg
09-06-2013 B2 G 2 208 hospitalized in
Greece
2 blaOXA-23,
blaOXA-66,
blaADC-25,
blaTEM-1D
aph(3′)-Ic, aph(3′)-Ic,
armA, strA, strB, mrs(E),
mph(E), tet(B)
AMA
495
urinary
catheter
14-09-2013 B2 G 2 208 same SNP
profile as
AMA 441
stayed in the same
nursing home as
patient with
AMA 441
none 2 blaOXA-23,
blaOXA-66,
blaADC-25,
blaTEM-1D
aph(3′)-Ic, aph(3′)-Ic,
armA, strA, strB, mrs(E),
mph(E), tet(B)
AMA
517
respiratory
secretions
04-10-2013 A NT 1 812 born in Serbia 1 blaOXA-72,
blaOXA-92,
blaTEM-1D
aadA1, aac(6′)Ib-cr,
aph(3′)-VI-a, aph(3′)Ic,
catA1, sul1, tet(A)
AMA
525
respiratory
secretions
14-10-2013 A NT 1 812 same SNP
profile as
AMA 517
this patient stayed in
the same hospital
roomas the patient
with AMA 517
none 1 blaOXA-72,
blaOXA-92,
blaTEM-1D
aadA1, aac(6′)Ib-cr,
aph(3′)-VI-a, aph(3′)Ic,
catA1, sul1, tet(A)
AMA
520
sputum 11-10-2013 B1 I 2 195 born in Pakistan 1 blaOXA-23,
blaOXA-66,
blaADC-25
armA, strA, strB, mph(E),
mrs(E), sul2, tet(B)
AMA
524
sputum 14-10-2013 B1 I 2 195 same SNP
profile as
AMA 520
this patient stayed in
the same hospital
ward as the patient
with AMA 520
none 1 blaOXA-23,
blaOXA-66,
blaADC-25
armA, strA, strB, mph(E),
mrs(E), sul2, tet(B)
NT, non-typeable.
aResistance profiles: profile 1, resistant to ampicillin/sulbactam, ticarcillin/clavulanic acid, piperacillin/tazobactam, ceftriaxone, cefotaxime, ceftazidime, cefoperazone, cefepime, aztreo-
nam, imipenem, meropenem, lomefloxacin, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, gentamicin, tobramycin, amikacin and tetracycline; and profile 2, as profile 1,
except susceptible to trimethoprim/sulfamethoxazole.
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The phylogenetic analyses showed that six of the eight Danish
A. baumannii isolates clustered into three clusters each consisting
of two isolates (Table 1). AMA 474 and AMA 341 did not cluster
with other Danish or international isolates included in the study.
The PFGE, MLST and SNP profiles discarded the suspicion of
an outbreak consisting of all four isolates detected in October
2013, but strongly suggested a spread of carbapenem-resistant
A. baumannii in three instances: between two patients (with
AMA 517 and AMA 525) staying in the same room during hospital-
ization; between two patients hospitalized in the sameward (with
AMA 520 and AMA 524); and between two patients living in the
same nursing home (with AMA 441 and AMA 495) (Table 1). In
addition to the blaOXA genes, 8–13 other resistance genes were
identified from the assembled genomes. In silico analyses showed
isolates sharing SNP profiles and Oxford MLST profiles had identi-
cal resistance gene profiles (Table 1). The isolates were resistant to
almost all tested antimicrobial agents and patterns were consist-
ent between the three sets of related isolates (Table 1).
MLST can be useful for investigation of global epidemiology. In
the present study, three of the patients had been travelling abroad
prior to OXA-carbapenemase detection and two persons were of
foreign ethnicity living in Denmark. The ST158 (Pasteur MLST) iso-
late was detected in a patient who had been to Egypt prior to
detection (Table 1). To our knowledge, ST158 is rare and has
only been reported from Iowa, USA, but ST615 and ST618,
which are single-locus variants of ST158, have been reported
from Egypt (Pasteur MLST).
The patient with A. baumannii ST218 (Oxford MLST) had been to
Slovakia prior to detection of the isolate; however, according to the
Oxford MLST database, ST218 has only been reported from Japan.
One of the two patients with ST208 (Oxford MLST) had been to
Greece before detection, but, according to the Oxford database,
ST208 has only been reported from Egypt, the USA and China.
One of the two patients with A. baumannii ST195 (Oxford MLST)
was a Pakistani male living in Denmark. A. baumannii ST195 has
previously been reported from several Asian countries.16,17
Furthermore, Karah et al.18 found an ST195 OXA-23-like-producing
A. baumannii in Norway from a patient travelling to Thailand.
In conclusion, the SNP profile, Oxford MLST and the resistance
gene profiles obtained from the WGS data were useful for typing
of the eight carbapenem-resistant A. baumannii. WGS analysis,
including SNP calling, MLSTand resistance gene profiles, adds sig-
nificant information for comparison and potential tracing of
international-spreading clones and should replace PFGE typing.
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